Laijun Xu, Lingzhi Li, Shouliang Zhao, Shangfeng Liu
{"title":"Recent Advances and Molecular Pathway in Salivary Adenoid Cystic Carcinoma (Review)","authors":"Laijun Xu, Lingzhi Li, Shouliang Zhao, Shangfeng Liu","doi":"10.2174/1574362414666190204124731","DOIUrl":null,"url":null,"abstract":"\n\nSalivary Adenoid Cystic Carcinoma (ACC) is a malignant tumor located\nat oral and maxillofacial regions, and its conventional treatments are surgery, chemotherapy and\nradiotherapy. However, its poor survival rates and prognosis resulting from the molecular mechanisms\nunderlying the carcinogenesis remain obscure. To date, there are insufficient reviews to\nsummarize the genes and molecular pathways for ACC. Therefore, it is required for us to highlight\nthe main oncogenes, tumor suppressor genes and genetic signal transduction pathways associated\nwith ACC in this review.\n\n\n\nA literature review based on PubMed for the genetic characteristics and\nmolecular transduction pathways for ACC was conducted. Ninety articles were selected as references\nusing the search terms or keywords such as “genes, molecular pathways, salivary adenoid\ncystic carcinoma or ACC”.\n\n\n\nWe have briefly described histopathology, current treatments and main clinical features\nin ACC. Besides, we have also elaborated the associated genes and pathways in this review according\nto the searched articles in recent years.\n\n\n\n We have summarized vital genes and proteins targeting or mechanism-based on proliferation,\napoptosis, invasion and metastasis. Although there are few kinds of research on ACC\ncurrently exist, we expect that better detailed genetic studies would pave the way for promising\nadvancement in our understanding of the molecular biology and pathogenesis mechanisms underlying\ntumors.\n","PeriodicalId":10868,"journal":{"name":"Current Signal Transduction Therapy","volume":"15 1","pages":"197-207"},"PeriodicalIF":0.0000,"publicationDate":"2020-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.2174/1574362414666190204124731","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current Signal Transduction Therapy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2174/1574362414666190204124731","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0
Abstract
Salivary Adenoid Cystic Carcinoma (ACC) is a malignant tumor located
at oral and maxillofacial regions, and its conventional treatments are surgery, chemotherapy and
radiotherapy. However, its poor survival rates and prognosis resulting from the molecular mechanisms
underlying the carcinogenesis remain obscure. To date, there are insufficient reviews to
summarize the genes and molecular pathways for ACC. Therefore, it is required for us to highlight
the main oncogenes, tumor suppressor genes and genetic signal transduction pathways associated
with ACC in this review.
A literature review based on PubMed for the genetic characteristics and
molecular transduction pathways for ACC was conducted. Ninety articles were selected as references
using the search terms or keywords such as “genes, molecular pathways, salivary adenoid
cystic carcinoma or ACC”.
We have briefly described histopathology, current treatments and main clinical features
in ACC. Besides, we have also elaborated the associated genes and pathways in this review according
to the searched articles in recent years.
We have summarized vital genes and proteins targeting or mechanism-based on proliferation,
apoptosis, invasion and metastasis. Although there are few kinds of research on ACC
currently exist, we expect that better detailed genetic studies would pave the way for promising
advancement in our understanding of the molecular biology and pathogenesis mechanisms underlying
tumors.
期刊介绍:
In recent years a breakthrough has occurred in our understanding of the molecular pathomechanisms of human diseases whereby most of our diseases are related to intra and intercellular communication disorders. The concept of signal transduction therapy has got into the front line of modern drug research, and a multidisciplinary approach is being used to identify and treat signaling disorders.
The journal publishes timely in-depth reviews, research article and drug clinical trial studies in the field of signal transduction therapy. Thematic issues are also published to cover selected areas of signal transduction therapy. Coverage of the field includes genomics, proteomics, medicinal chemistry and the relevant diseases involved in signaling e.g. cancer, neurodegenerative and inflammatory diseases. Current Signal Transduction Therapy is an essential journal for all involved in drug design and discovery.